Stemgenics, Inc. — Form D/A
Stemgenics, Inc. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2018-01-11. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-01-11
- Form: D/A
- Accession: 0001595336-18-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.8M
- Amount sold: $1.8M
- Investors: 39
- Date of first sale: 2015-12-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-255128
Issuer
- Name: Stemgenics, Inc.
- CIK: 0001595336
- Entity type: Corporation
- Jurisdiction: WASHINGTON
- Address: 454 N. 34TH STREET, SEATTLE, WA, 98103
- Phone: 206-819-9433
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Mushegh S Hovhannisyan | Director | Seattle, WA |
| Mushegh S Hovhannisyan | Executive Officer | Seattle, WA |
| Frederick S Hagen | Director | Seattle, WA |
| Frederick S Hagen | Executive Officer | Seattle, WA |
| Andranik S Aprikyan | Director | Seattle, WA |
| Andranik S Aprikyan | Executive Officer | Seattle, WA |
| Anush S Oganesian | Director | Seattle, WA |
| Mushegh Hovhannisyan | Director | Seattle, WA |
| Mushegh Hovhannisyan | Executive Officer | Seattle, WA |
| Frederick Hagen | Director | Seattle, WA |
| Frederick Hagen | Executive Officer | Seattle, WA |
| Andranik Aprikyan | Director | Seattle, WA |
| Andranik Aprikyan | Executive Officer | Seattle, WA |
Other filings by this issuer (3)
More